GIL BASHE ON MEDIKA LIFE

ViVE 2025: Breakthrough Moments in Health Innovation

How AI Startups and Industry Giants Are Reshaping Health Systems, Reducing Costs, and Improving Patient Care

Day Two of ViVE 2025 is over. Friends old and new are attending one of the many end-of-day receptions that invite continued conversation. This gathering continues as a must-attend event for providers, health tech innovators, and health information professionals exchanging ideas during this three-day event—a jam-packed exhibit hall room centered around multiple main-stage conversations that are generally standing-room-only presentations.

Along with the presence of the CHIME community, ViVE offers an opportunity for more than 8,000 health leaders—including a sizable number of C-suite executives—to engage in operational and “from the heart” exchanges shaping a long-awaited sector transformation – from fragmented to fluid.

Nashville, celebrated nationally as Music City and an epicenter of health innovation, may play a Swiss-like role in the much-needed shift that must happen sooner rather than later. It is a city of possibilities and a health community built around purpose, entrepreneurial energy, and a collaborative mindset.  If changes in the health system are remotely possible, it is because the town’s ” vibe ” is inclusive and built on realizing dreams and hopes.

At ViVE, the conversation around Artificial Intelligence (AI) has evolved dramatically during the past four meetings. What was once speculative hocus-pocus is now embraced as essential and operational. AI is often mischaracterized as “artificial intelligence.” The correct term that should be applied to the reality of its integration in the workflow is “augmented implementation,” a tool that amplifies human capabilities rather than replacing them. This distinction is key to understanding that AI fits into the health ecosystem’s future, where precision, trust, and efficiency converge.

A recent report from MarketsandMarkets states that the AI in healthcare market size is estimated to surge from USD 20.9 billion in 2024 to USD 148.4 billion by 2029.

The Evolution from Theory to Practice

Reflecting on previous ViVE conferences, the discussion around AI was theoretical and focused on potential applications, ethical considerations, and integration challenges. At ViVE 2025, that narrative continues to head in a focused endpoint direction. AI advancements through ChatGPT and large language models (LLMs) are a given asset embedded in health workflow.

Sessions now showcase real-world applications, from AI-driven clinical decision support to streamlined administrative processes and enhanced patient engagement. The focus is no longer on possibility but on action—how organizations can effectively harness AI to improve outcomes and efficiency in care and cost.

Addressing Cost Inefficiencies and Workflow Optimization

The buzz on the stage and exhibit hall is a common message. One of the most critical aspects of AI integration into health is its potential to address repetitive actions and overcome systemic challenges. Leveraging AI and data analytics, health professionals can identify disease and diagnostic possibilities that escape their training eye and imagination, reduce cost inefficiencies, and optimize health system workflows – from procedure and patient scheduling to finding correct billing codes.

AI-driven insights enable a more equitable distribution of resources, ensuring that underserved populations receive the care they need when needed. Moreover, automating administrative tasks should free up time for clinicians, reducing burnout and allowing them to focus on patient-centered care.

Major Players Accelerate AI Adoption

Industry giants like Amazon, Epic, Microsoft, and Oracle are propelling the rapid integration of AI into health care. These companies are not just developing AI tools that others use as platforms but fostering collaborations to ensure seamless integration within existing health infrastructures.

Amazon: With a strategic investment of up to $4 billion in Anthropic, Amazon is expanding its generative AI capabilities within Amazon Web Services (AWS). Its initiative aims to equip health organizations with advanced AI-driven tools to enhance patient care and operational efficiency.

Epic: Beyond its Microsoft partnership, Epic continues to lead in AI integration, ensuring providers can access cutting-edge tools to improve clinical decision-making and patient engagement.

Microsoft: To deepen collaboration with Epic, Microsoft has embedded its Azure OpenAI Service into the Epic electronic health record (EHR) software. This integration enables generative AI tools to optimize clinical workflows, reduce administrative burdens, and enhance decision-making.

Oracle: Recognizing AI transformative potential, Oracle has introduced generative AI tools within its EHR systems. These tools automate routine tasks, allowing health professionals to devote more time to patient care.

Entrepreneurial Companies Driving Change

ViVE is not only about the industry’s most prominent health IT players coming together under one roof but also a platform where entrepreneurial companies push the industry forward. Smaller AI-driven start-ups and health tech service providers function as a pipeline for innovation, capturing media attention and influencing companies’ mergers and acquisitions (M&A) and investment strategies.

Here are three companies that started small and have become sector change agents:  

Abridge: In February 2025, Abridge raised a $250 million Series D investment that now has the company valued at $2.5 billion. This funding supports deploying their AI-driven clinical documentation platform across more than 100 health systems, including prominent institutions like Duke Health, Johns Hopkins, Mayo Clinic, and UNC Health. The investment also fuels the development of its new Contextual Reasoning Engine, designed to produce billable clinical notes at the point of care, streamlining workflows and reducing administrative burdens.

Cohere Health: Cohere Health is a clinical intelligence company transforming the prior authorization process. By leveraging artificial intelligence, Cohere streamlines administrative paperwork, expediting patient access to necessary care. Their mission is to simplify health by fostering collaboration among patients, physicians, and health plans, ensuring the proper care is delivered promptly and effectively.

Qventus: In January 2024, Qventus announced a $105 million Series D investment led by powerhouse KKR, with participation from Bessemer Venture Partners and investors such as Northwestern Medicine, HonorHealth and Allina Health. This funding aims to enhance Qventus AI-based care automation software, optimizing hospital operations by predicting patient flow and reducing inefficiencies that impact revenues.

These entrepreneurial players—now operating at scale and resourced—challenge industry norms and encourage the mega information players to rethink how their platforms can be the “Intel-inside” service provider systems.

Collaboration is the Catalyst for Innovation

The true power of AI in health emerges from collaboration. Collaboration among technology leaders and health institutions drives innovation, ensuring AI solutions address real-world challenges. That has been a clear message during ViVE 2025.

The Microsoft-Epic collaboration is a driver in integrating AI within EHRs to analyze vast datasets, providing clinicians with actionable insights that improve patient care. Similarly, the Amazon investment in Anthropic is advancing generative AI to enhance health operations. These alliances demonstrate how combining technological expertise with health knowledge leads to breakthrough solutions.

ViVE has become a welcoming platform for fostering these collaborations, bringing health and technology leaders together to discuss AI’s practical applications. The 2025 meeting agenda reflects this focus, offering hands-on sessions that provide attendees with tangible AI implementation strategies and case studies.

The Future of Augmented Implementation in Health

Gil Bashe, FINN Partners, Chair Global Health and Purpose and Editor-in-Chief, Medika Life, talks with Healthcare IT Today editors about AI as augmented implementation and what CIOs need to talk about within their health systems.

The “augmented implementation” concept is more relevant than ever as we stand at the intersection of technology and health – and a new Administration pushing AI as an elixir for what ails the industry and US global competitiveness. While many wonder whether AI will replace human expertise, there is little debate about whether it will enable more transparent decision-making and efficient care delivery.

The shift from theoretical discussion to practical application has been faster than expected, fueled by collaboration, innovation, and a shared hope for improved patient care. The AI footprint in health will continue to expand, and its success will depend on maintaining a balance between technological advancement and human-centered care.

ViVE is a time capsule of obstacles, anxieties, and health system progress integrated with our combined wisdom into practice. Conversations continue to evolve, collaborations deepen, and applications become more practical. As we continue to embrace “augmented implementation,” the future of health is encouraging—where technology amplifies human potential and delivers unparalleled value to patients and providers alike. ViVE continues to be a place for open, candid exchange.

PATIENT ADVISORY

Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

Gil Bashe, Medika Life Editor
Gil Bashe, Medika Life Editorhttps://gil-bashe.medium.com/
Health advocate connecting the dots to transform biopharma, digital health and healthcare innovation | Managing Partner, Chair Global Health FINN Partners | MM&M Top 50 Health Influencer | Top 10 Innovation Catalyst. Gil is Medika Life editor-in-chief and an author for the platform’s EcoHealth and Health Opinion and Policy sections. Gil also hosts the HealthcareNOW Radio show Healthunabashed, writes for Health Tech World, and is a member of the BeingWell team on Medium.

GIL BASHE

Editor in Chief, Medika Life

Meet the Medika Life editor-in-chief, working closely with founding editors Robert Turner and Jeff Livingston, MD.

Not your usual health-industry executive, Gil Bashe has had a unique career shaped by more than three decades in health policy, pharma, life science, digital health, eco-health, environmental innovation and venture capital and informed his determination to ‘give back.’

A champion for health innovation that sustains people’s lives and improves their care, Gil honed his perspectives on both battlefield and boardroom. He started in health as a combat medic in an elite military unit. He went on to serve as a clergyman tending to the ill; as a health products industry lobbyist in environmental affairs; as CEO of one of the world’s largest integrated health marketing companies; as a principal in a private equity-backed venture; as a Medika Life author and Health Tech World correspondent; and as Chair Global Health and Purpose at FINN Partners, a community of purpose dedicated to making a difference.

In the forefront of change, Gil is ranked as a Top 10 Digital Health Influencer; Medical Marketing & Media Top 10 Innovation Catalyst; Medika Life named him a “Top 50 Global Healthcare Influencer,” and PM360 presented him with its “Trailblazer Lifetime Achievement Award.” He is a board member for digital health companies and is an advisor to the CNS Summit, Galien Foundation, Let’s Win for Pancreatic Cancer, Marfan Foundation and other health-centered organizations.

CONNECT WITH GIL

ON TWITTER

ON LINKEDIN

ON MEDIUM

All articles, information and publications featured by the author on thees pages remain the property of the author. Creative Commons does not apply and should you wish to syndicate, copy or reproduce, in part or in full, any of the content from this author, please contact Medika directly.